Market Capitalization | 37.6M |
Book Value | $1.69 |
Earnings Per Share (EPS) | -0.13 |
PEG Ratio | 0.0 |
Wall Street Target Price | 1.47 |
Profit Margin | -8.41% |
Operating Margin TTM | -16.7% |
Return On Assets TTM | -5.89% |
Return On Equity TTM | -7.65% |
Revenue TTM | 31.9M |
Revenue Per Share TTM | 1.59 |
Quarterly Revenue Growth YOY | 10.5% |
Gross Profit TTM | 5.5M |
EBITDA | -3.4M |
Diluted Eps TTM | -0.13 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
A Spac I Acquisition Corp
$1.89
+0.0%
Gamida Cell Ltd
$1.89
+0.0%
Palladyne Ai Corp
$1.89
+0.0%
Keyarch Acquisition Corp
$1.89
+0.0%
Acorda Therapeutics, Inc.
$1.89
+0.0%
Connexa Sports Technologies Inc
$1.89
+0.0%
Semantix Inc
$1.89
+0.0%
Arrowroot Acquisition Corp-a
$1.89
+0.0%
Anfield Capital Diversified Alternatives Etf
$1.89
+0.0%